By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Antibe Therapeutics Inc. 

1063 King St. West
Suite 210
Hamilton  Ontario  L8S 4S3  Canada
Phone: 905-515-6132 Fax: 905-528-9862



Company News
Antibe Therapeutics (ATE.V) Announces The Launch Of Neomem FlexPlus, A High-Performance Barrier Membrane For Oral Surgery 8/16/2016 10:18:00 AM
Antibe Therapeutics (ATE.V) Announces Successful Phase 2 Trial Of ATB-346 In Osteoarthritis 8/8/2016 10:28:09 AM
Antibe Therapeutics (ATE.V) Reports 2016 Year-End Financial And Operating Results 8/1/2016 11:29:26 AM
Antibe Therapeutics (ATE.V) Announces the Appointment of New Board Member and Provides Update on Phase 2 Trial of ATB-346 7/19/2016 11:46:32 AM
Antibe Therapeutics (ATE.V) Raises $968,500 In First Tranche Of Non-Brokered Private Placement 6/13/2016 11:15:24 AM
Antibe Therapeutics (ATE.V) Presenting Update On ATB-346 At International Hydrogen Sulfide Conference 5/31/2016 12:59:40 PM
Antibe Therapeutics (ATE.V) To Present At 2016 Bloom Burton & Co. Healthcare Investor Conference 5/2/2016 10:56:36 AM
Antibe Therapeutics (ATE.V) Announces The Launch Of PentOS OI Putty, A High-Quality Bone Graft Substitute For Oral And Maxillofacial Surgery 4/18/2016 10:56:28 AM
Antibe Therapeutics (ATE.V) Announces Appointment Of The Giordano Group, Inc, A Division Of Network 1 Financial Securities LLC, As US-BASED Investor Relations Consultant 4/1/2016 10:19:34 AM
Antibe Therapeutics (ATE.V) Announces Grant Of Stock Options 3/10/2016 11:01:24 AM